We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
-0.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$60.5B
AUM Growth
+$2.39B
Cap. Flow
+$1.77B
Cap. Flow %
2.93%
Top 10 Hldgs %
17.56%
Holding
4,827
New
882
Increased
1,455
Reduced
1,567
Closed
849

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$210M
2
UNH icon
UnitedHealth
UNH
+$158M
3
NFLX icon
Netflix
NFLX
+$140M
4
DG icon
Dollar General
DG
+$135M
5
MU icon
Micron Technology
MU
+$124M

Sector Composition

Rank Sector Weight
1 Technology 9.07%
2 Consumer Discretionary 6.01%
3 Healthcare 4.63%
4 Industrials 4.29%
5 Financials 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APEI icon
3151
American Public Education
APEI
$917M
$449K ﹤0.01%
25,516
-28,469
-53% -$447K
DGICA icon
3152
Donegal Group Class A
DGICA
$711M
$448K ﹤0.01%
+34,817
New +$462K
COMP icon
3153
Compass
COMP
$8.88B
$447K ﹤0.01%
+124,292
New +$456K
VNDA icon
3154
Vanda Pharmaceuticals
VNDA
$310M
$447K ﹤0.01%
79,030
-156,573
-66% -$809K
VRA icon
3155
CALL
Vera Bradley
VRA
$104M
$446K ﹤0.01%
+71,300
New +$496K
VTRS icon
3156
Viatris
VTRS
$20.8B
$446K ﹤0.01%
41,971
-341,543
-89% -$3.77M
CFG icon
3157
Citizens Financial Group
CFG
$30.8B
$444K ﹤0.01%
12,331
-48,054
-80% -$1.68M
NEOG icon
3158
Neogen
NEOG
$2B
$444K ﹤0.01%
+28,415
New +$395K
OCUL icon
3159
Ocular Therapeutix
OCUL
$1.85B
$444K ﹤0.01%
64,911
+47,614
+275% +$294K
EXC icon
3160
PUT
Exelon
EXC
$48.4B
$443K ﹤0.01%
+12,800
New +$472K
KRYS icon
3161
Krystal Biotech
KRYS
$10.7B
$442K ﹤0.01%
+2,408
New +$404K
ARI
3162
Apollo Commercial Real Estate
ARI
$881M
$442K ﹤0.01%
+45,167
New +$466K
ARTNA icon
3163
Artesian Resources
ARTNA
$361M
$441K ﹤0.01%
+12,552
New +$455K
AXGN icon
3164
Axogen
AXGN
$2.19B
$441K ﹤0.01%
60,913
+39,624
+186% +$271K
DLR icon
3165
CALL
Digital Realty Trust
DLR
$71.5B
$441K ﹤0.01%
2,900
-79,800
-96% -$11.5M
CMPR icon
3166
Cimpress
CMPR
$2.43B
$441K ﹤0.01%
+5,028
New +$438K
BBY icon
3167
Best Buy
BBY
$18.9B
$440K ﹤0.01%
5,218
+19
+0.4% +$1.51K
EVH icon
3168
Evolent Health
EVH
$421M
$439K ﹤0.01%
+22,980
New +$587K
RDFN
3169
PUT
DELISTED
Redfin
RDFN
$439K ﹤0.01%
73,000
-342,000
-82% -$2.14M
OZK icon
3170
PUT
Bank OZK
OZK
$5.62B
$439K ﹤0.01%
+10,700
New +$466K
ACET icon
3171
Adicet Bio
ACET
$76.7M
$438K ﹤0.01%
22,639
+21,839
+2,730% +$585K
ZWS icon
3172
Zurn Elkay Water Solutions
ZWS
$8.23B
$438K ﹤0.01%
+14,908
New +$470K
VIPS icon
3173
Vipshop
VIPS
$7.13B
$438K ﹤0.01%
+33,624
New +$535K
POST icon
3174
CALL
Post Holdings
POST
$4.27B
$437K ﹤0.01%
4,200
+600
+17% +$62.5K
GT icon
3175
PUT
Goodyear
GT
$2.12B
$437K ﹤0.01%
38,500
-150,200
-80% -$1.84M

Similar funds

Squarepoint's Q2 2024 Portfolio in Review

As of Q2 2024, Squarepoint held 4,827 positions worth $60.5B, up 4.1% from $58.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Squarepoint's Q2 2024 filing shows 882 new, 1,455 increased, 1,567 reduced and 849 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M. The largest sale was Apple, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 8.5% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Squarepoint's largest Q2 2024 buy was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M.
  • Squarepoint added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.29B increase.
  • Squarepoint's biggest Q2 2024 reduction was Apple, cutting an estimated $210M.
  • Squarepoint fully exited DraftKings in Q2 2024, selling an estimated $94.6M.
  • Squarepoint's ten largest holdings make up 18% of its $60.5B portfolio in Q2 2024.
  • Squarepoint opened 882 new positions and closed 849 in Q2 2024.
  • Squarepoint's portfolio value rose 4.1% quarter-over-quarter to $60.5B.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.